ABILIFY Safety Questions, ABILIFY Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ABILIFY. Our extensive database of ABILIFY adverse events and ABILIFY warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ABILIFY

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




ABILIFY Safety Reports

Total ABILIFY reports: 951.
ABILIFY FDA safety alerts: 2004 .
Reported deaths: 85    Reported hospitalizations: 204.
Take ABILIFY Side Effects Survey or Share Your ABILIFY Story. ABILIFY Usage.

< Previous  Showing 151-225 of 951 Next >

Physician from UNITED STATES reported ABILIFY problem on Jan 23, 2006. Male patient, 16 years of age, was diagnosed with bipolar disorder, attention deficit/hyperactivity disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: dystonia. ABILIFY dosage: unknown. During the same period patient was treated with SEROQUEL. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Jan 23, 2006. Female patient was diagnosed with bipolar i disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: blepharospasm, tardive dyskinesia. ABILIFY dosage: ABILIFY: DOSE INCREASED TO 15MG QD IN 2004 WITHIN 2 WEEKS OF INITIATION; DOSE DECREASED IN OCT-2005. During the same period patient was treated with WELLBUTRIN, LAMICTAL. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on June 07, 2006. Female patient, 35 years of age, was diagnosed with schizophrenia and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: excessive eye blinking, eyelid ptosis, tremor. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Jan 25, 2006. Female patient, 54 years of age, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. ABILIFY dosage: ABILIFY: STARTED ON 2.5MG ON 22-OCT-2004; GRADUALLY TITRATED TO CURRENT DOSE OF 15MG DAILY.. During the same period patient was treated with LAMICTAL, DEPAKOTE, NEURONTIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Jan 27, 2006. Male patient, 72 years of age, weighting 172.0 lb, was diagnosed with anger and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, headache, hunger, insomnia, pain in extremity, rash, treatment noncompliance, vision blurred. ABILIFY dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, TIMOLOL MALEATE, CALCIUM, VITAMINS. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Jan 30, 2006. Male patient, 35 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: hyperthermia. ABILIFY dosage: unknown. During the same period patient was treated with HALDOL. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Jan 27, 2006. Male patient, 43 years of age, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: vision blurred. ABILIFY dosage: unknown. During the same period patient was treated with WELLBUTRIN. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Jan 30, 2006. Female patient was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: tardive dyskinesia. ABILIFY dosage: 5-10 MG DAILY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Jan 31, 2006. Male patient, 25 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: vomiting. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2006. Female patient, 16 years of age, weighting 130.1 lb, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: feeling hot, headache, vomiting. ABILIFY dosage: unknown. During the same period patient was treated with CYMBALTA, ORTHO TRI, PREVACID. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Apr 12, 2006. Female patient, 24 years of age, weighting 165.3 lb, was diagnosed with depression and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder, vision blurred. ABILIFY dosage: unknown. During the same period patient was treated with EFFEXOR, CONTRACEPTIVE. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Jan 31, 2006. Female patient was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: chest pain. ABILIFY dosage: INITALLY 1 MG THEN INCREASED TO 3 MG.. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 01, 2006. Female patient, 48 years of age, weighting 235.9 lb, was diagnosed with schizoaffective disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: accidental overdose. ABILIFY dosage: 23DEC05 15 MG, 30DEC05 20 MG/D, 09JAN06 30 MG/D, UNK 30 MG QID (INSTEAD OF 45 MG/D), FEB06 30 MG BID. During the same period patient was treated with PAXIL, AMBIEN, SEROQUEL. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2006. Female patient, 25 years of age, weighting 280.0 lb, was diagnosed with bipolar disorder, depression and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: diarrhoea, tremor, weight decreased. ABILIFY dosage: unknown. During the same period patient was treated with EFFEXOR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 01, 2006. Male patient, 55 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: cardiac flutter, palpitations, ventricular extrasystoles. ABILIFY dosage: unknown. During the same period patient was treated with LEXAPRO, ACEBUTOLOL. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2006. Male patient, 30 years of age, weighting 189.6 lb, was diagnosed with schizoaffective disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: pyrexia, tremor. ABILIFY dosage: unknown. During the same period patient was treated with PERMITIL, ZYPREXA, LITHIUM CARBONATE, TOPAMAX, LUVOX, CONCERTA, XANAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 02, 2006. Female patient, child 12 years of age, weighting 130.1 lb, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Jan 31, 2006. Male patient, 15 years of age, weighting 200.6 lb, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. ABILIFY dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Feb 02, 2006. Female patient, 20 years of age, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: visual disturbance. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Apr 24, 2006. Female patient, 50 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: arthralgia. ABILIFY dosage: INITALLY DOSED AT 5 MG,THEN STOPPED, THEN REINTRODUCED AT 5 MG,THEN REDUCED TO 4 MG IN LIQUID FORM.. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 02, 2006. Female patient, 15 years of age, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: pregnancy. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2006. Female patient, 58 years of age, weighting 202.8 lb, was diagnosed with schizoaffective disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, memory impairment, tremor. ABILIFY dosage: unknown. During the same period patient was treated with ZOCOR, ZETIA, AMBIEN, XANAX, DIOVAN, PROZAC, BENZTROPINE MESYLATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 06, 2006. Female patient, 32 years of age, weighting 233.7 lb, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: somnolence, vomiting. ABILIFY dosage: unknown. During the same period patient was treated with NEURONTIN, TRILEPTAL, TRAZODONE, PREVACID, LOPID, EFFEXOR. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2006. Male patient, weighting 180.8 lb, was diagnosed with schizophrenia and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: hallucination, auditory, nightmare. ABILIFY dosage: unknown. During the same period patient was treated with SEROQUEL, LEXAPRO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 07, 2006. Male patient, weighting 185.2 lb, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: feeling jittery. ABILIFY dosage: unknown. During the same period patient was treated with ASACOL, NEXIUM. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2006. Female patient, child 12 years of age, weighting 85.98 lb, was diagnosed with agitated depression, affective disorder, borderline personality disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: headache, pyrexia. ABILIFY dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 08, 2006. Female patient, 48 years of age, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: vision blurred. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Feb 07, 2006. Male patient, weighting 125.7 lb, was diagnosed with affective disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: weight increased. ABILIFY dosage: unknown. During the same period patient was treated with LEXAPRO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 09, 2006. Female patient was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: tooth infection. ABILIFY dosage: 5MG OR 10 MG DAILY. During the same period patient was treated with TEGRETOL, TRAZODONE, EFFEXOR. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Feb 09, 2006. Female patient, child 10 years of age, was diagnosed with autism and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: muscle spasms. ABILIFY dosage: unknown. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Feb 09, 2006. Female patient, 53 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: oedema peripheral. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 10, 2006. Male patient, 23 years of age, weighting 145.5 lb, was diagnosed with schizophrenia and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: confusional state, hyperhidrosis, vision blurred. ABILIFY dosage: INITALLY DOSE WAS 30 MG/D. IT WAS DECREASED INCREMENTALLY DOWN TO 5 MG/D.. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Feb 09, 2006. Male patient, 35 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: tremor. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2006. Female patient, 38 years of age, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: tardive dyskinesia. ABILIFY dosage: unknown. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Feb 06, 2006. Female patient, 34 years of age, was diagnosed with bipolar disorder, post-traumatic stress disorder, dissociation and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: tardive dyskinesia. ABILIFY dosage: unknown. During the same period patient was treated with ZOLOFT, DEPAKOTE, ATIVAN. Patient recovered.

ABILIFY problem was reported by a Health Professional from UNITED STATES on Feb 15, 2006. Male patient, 29 years of age, was diagnosed with abnormal behaviour, aggression and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: convulsion. ABILIFY dosage: unknown. During the same period patient was treated with LAMICTAL, TOPAMAX, KLONOPIN, SYNTHROID, ASCORBIC ACID, MAGNESIUM. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Feb 15, 2006. Female patient, child 10 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: dyskinesia. ABILIFY dosage: unknown. During the same period patient was treated with LAMICTAL, CLONIDINE. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2006. Female patient, 15 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: amnesia, hallucination, paranoia, sexual assault victim. ABILIFY dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported ABILIFY problem on Feb 16, 2006. Female patient, 16 years of age, weighting 136.7 lb, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: vision blurred. ABILIFY dosage: unknown. During the same period patient was treated with ESKALITH CR, KLONOPIN, LAMICTAL, ASCORBIC ACID. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 17, 2006. Female patient, 53 years of age, weighting 187.4 lb, was diagnosed with schizophrenia and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: weight increased. ABILIFY dosage: unknown. During the same period patient was treated with AMANTADINE, TAMOXIFEN CITRATE, AVALIDE, LIPITOR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 17, 2006. Female patient, 17 years of age, weighting 130.1 lb, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: diarrhoea, vomiting. ABILIFY dosage: unknown. During the same period patient was treated with LAMICTAL. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 17, 2006. Female patient, child 12 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: body temperature increased, headache. ABILIFY dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 21, 2006. Female patient, child 7 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: movement disorder. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 21, 2006. Male patient, weighting 149.9 lb, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: muscular weakness, restless legs syndrome. ABILIFY dosage: BETWEEN 12.5MG AND 25MG. During the same period patient was treated with SEROQUEL, VYTORIN, XANAX, OMEPRAZOLE. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Feb 22, 2006. Female patient, 48 years of age, was diagnosed with insomnia and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: pre-existing condition improved. ABILIFY dosage: STARTED AT 5 MG/D GRADUALLY INCREASED TO 30 MG -} 12-FEB-2006 PATIENT INCREASED DOSE TO 45 MG/D. During the same period patient was treated with CLONAZEPAM, LANTUS, HUMALOG, VICODIN, DURAGESIC. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2006. Female patient, 52 years of age, weighting 138.9 lb, was diagnosed with bipolar disorder, mania and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: somnolence. ABILIFY dosage: 8-FEB-2006 PATIENT INCREASED DOSE TO 7.5 MG/D -} 16-FEB-2006 PHSYICIAN INCREASED DOSE TO 10MG/D. During the same period patient was treated with LAMICTAL, AMBIEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 23, 2006. Female patient, 24 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 23, 2006. Female patient, weighting 165.3 lb, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: somnolence. ABILIFY dosage: unknown. During the same period patient was treated with WELLBUTRIN, LEXAPRO, TRILEPTAL. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Mar 21, 2006. Male patient, child 8 years of age, was diagnosed with bipolar disorder, attention deficit/hyperactivity disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, vomiting. ABILIFY dosage: unknown. Patient was hospitalized. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2006. Male patient, 63 years of age, weighting 218.3 lb, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: heart rate increased, heart rate irregular, pain in extremity, sedation. ABILIFY dosage: unknown. During the same period patient was treated with CARDIZEM, COUMADIN, PRINIVIL, NORVASC, DIOVAN, MICROZIDE, LASIX, TRICOR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Feb 27, 2006. Female patient, child 7 years of age, weighting 149.9 lb, was diagnosed with bipolar disorder, thyroid disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: dystonia. ABILIFY dosage: unknown. During the same period patient was treated with ADDERALL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2006. Male patient, 19 years of age, weighting 48.50 lb, was diagnosed with attention deficit/hyperactivity disorder, autism and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: anorexia, dizziness, feeling hot, vomiting. ABILIFY dosage: unknown. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Apr 12, 2006. Female patient, 60 years of age, weighting 134.5 lb, was diagnosed with bipolar disorder, anxiety, mood swings and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: bone pain, euphoric mood, fear, logorrhoea, mania, mood swings, muscle spasms, somnolence, suicidal ideation. ABILIFY dosage: unknown. During the same period patient was treated with PREMARIN, SYNTHROID, LITHIUM CARBONATE, LITHIUM CARBONATE, GABAPENTIN. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 01, 2006. Female patient, child 10 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: eosinophilia. ABILIFY dosage: unknown. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Mar 01, 2006. Female patient was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: urinary retention. ABILIFY dosage: REDUCED TO 5 MG DAILY, THEN DISCONTINUED. During the same period patient was treated with SUPRAX. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2006. Male patient, 22 years of age, weighting 143.3 lb, was diagnosed with bipolar disorder, depression and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: candidiasis, hyperglycaemia, polydipsia. ABILIFY dosage: unknown. During the same period patient was treated with NORCO, NEXIUM, RECOMBINATE, REMERON, TENEX. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Mar 02, 2006. Female patient, 31 years of age, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2006. Female patient, 24 years of age, was diagnosed with bipolar disorder, contraception and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting, weight increased. ABILIFY dosage: unknown. During the same period patient was treated with CONTRACEPTIVE, LAMICTAL, LORAZEPAM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on June 12, 2006. Female patient, 60 years of age, was diagnosed with irritability and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: pain in extremity. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2006. Female patient, 28 years of age, weighting 220.5 lb, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: weight increased. ABILIFY dosage: unknown. During the same period patient was treated with PROVIGIL, STRATTERA, ZOLOFT. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Mar 13, 2006. Female patient, 14 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: menstruation irregular. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Mar 14, 2006. Female patient was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder. ABILIFY dosage: DOSE VALUE: 2.5 MG IN THE MORNING, AD 10 MG IN THE EVENING.. During the same period patient was treated with DEPAKOTE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Mar 13, 2006. Male patient, 25 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: hiccups. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2006. Male patient, 30 years of age, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: dysarthria, lip dry, vision blurred. ABILIFY dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Mar 15, 2006. Female patient, 15 years of age, weighting 99.21 lb, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: amenorrhoea. ABILIFY dosage: unknown. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Jan 23, 2006. Female patient was diagnosed with bipolar ii disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: dysgraphia, salivary hypersecretion, tardive dyskinesia. ABILIFY dosage: ABILIFY: STARTED ON 5MG QD 08-FEB-05; INCREASED TO 10MG QD 22-MAR-05; INCREASED TO 15MG QD MAY 2005.. During the same period patient was treated with TOPAMAX, EFFEXOR, ATIVAN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Mar 15, 2006. Male patient, 61 years of age, weighting 418.9 lb, was diagnosed with schizoaffective disorder, infection, sleep apnoea syndrome and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: asthenia, hunger, suicidal ideation. ABILIFY dosage: unknown. During the same period patient was treated with DEPAKOTE, AUGMENTIN, ALBUTEROL, OXYGEN. Patient recovered.

ABILIFY problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2006. Male patient, 35 years of age, was diagnosed with acne and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. ABILIFY dosage: unknown. During the same period patient was treated with PAXIL CR, LEXAPRO, ACNE LOTION. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Mar 15, 2006. Female patient, 14 years of age, weighting 233.7 lb, was diagnosed with abnormal behaviour, aggression and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: weight increased. ABILIFY dosage: unknown. During the same period patient was treated with CLONIDINE, CARBATROL, TRILEPTAL. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Mar 15, 2006. Male patient, child 12 years of age, was diagnosed with autism, bipolar disorder, aggression and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: weight increased. ABILIFY dosage: 20-30 MG. During the same period patient was treated with LORAZEPAM, SEROQUEL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ABILIFY problem on Mar 16, 2006. Female patient, 51 years of age, weighting 112.4 lb, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: hypotension, palpitations, peripheral coldness, skin discolouration, tremor. ABILIFY dosage: unknown. During the same period patient was treated with LAMICTAL. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Mar 16, 2006. Male patient, 16 years of age, was diagnosed with bipolar disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: breast mass. ABILIFY dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported ABILIFY problem on Mar 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with schizophrenia and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: vomiting. ABILIFY dosage: unknown. During the same period patient was treated with PAXIL, TOPAMAX, VITAMINS. Patient recovered.

ABILIFY problem was reported by a Physician from UNITED STATES on Apr 12, 2006. Female patient, 16 years of age, was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: dystonia, fatigue, intentional overdose, malaise. ABILIFY dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ABILIFY problem on Mar 16, 2006. Male patient, 16 years of age, was diagnosed with psychotic disorder and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: drooling, muscle rigidity, myalgia, tachycardia. ABILIFY dosage: unknown. Patient recovered.

< Previous  Showing 151-225 of 951 Next >

Ask Our Patient Community about ABILIFY

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)